The weekly litigation news digest is live. Subscribe now

IP Verse

Glucose Monitoring System - EP2581887

The patent EP2581887 was granted to Abbott on Apr 4, 2018. The application was filed on Feb 8, 2006 under application number EP13000105A. The patent is currently recorded with a legal status of "Revoked".

EP2581887

ABBOTT
Application Number
EP13000105A
Filing Date
Feb 8, 2006
Status
Revoked
Sep 27, 2019
Publication Date
Apr 4, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ABLETT WILLIAMS GAUNTJan 4, 2019WILLIAMSADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2006026741
OPPOSITIONUS2003114898
OPPOSITIONUS2005104457
OPPOSITIONUS2005247319
OPPOSITIONUS2005261563
OPPOSITIONUS2006012464
OPPOSITIONUS2006016700
OPPOSITIONUS5305008
OPPOSITIONUS5372133
OPPOSITIONUS5833603
OPPOSITIONUS6804561
SEARCHUS2005281706
SEARCHUS6942518
SEARCHWO2005040793

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents